Who owns ADAGIO THERAPEUTICS INC?
- Ticker: IVVD
- CUSIP Number: 00534a102
Tip: Access positions for across all investors
Analyze quarterly positions in Adagio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Adagio Therapeutics stock
Who bought or sold ADAGIO THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Maverick Capital | 12M | $12M | 0% | Sep 2024 |
|
Deep Track Capital | 11M | $12M | 0% | Jun 2024 |
|
M28 Capital Management | 9.2M | $9.4M | 0% | Sep 2024 |
|
BlackRock | 4.7M | $4.8M | 100% | Sep 2024 |
|
BlackRock | 4.5M | $4.9M | 410% | Jun 2024 |
|
Vanguard Group | 4.3M | $4.7M | 64% | Jun 2024 |
|
Slate Path Capital | 3.7M | $3.8M | 0% | Sep 2024 |
|
Redmile Group | 3.1M | $3.1M | 0% | Sep 2024 |
|
683 Capital Management | 3.0M | $3.1M | -17% | Sep 2024 |
|
Bain Capital Life Sciences Investors | 1.8M | $2.0M | 0% | Jun 2024 |
|
OrbiMed Advisors | 1.7M | $1.8M | -29% | Sep 2024 |
|
Geode Capital Management | 1.6M | $1.7M | -1% | Sep 2024 |
|
State Street Corporation | 983k | $1.1M | 418% | Jun 2024 |
|
Acadian Asset Management | 652k | $664k | -4% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 647k | $660k | 0% | Sep 2024 |
|
Citadel Advisors | 629k | $642k | 5581% | Sep 2024 |
|
Duquesne Family Office | 571k | $583k | 0% | Sep 2024 |
|
Northern Trust | 568k | $580k | 413% | Sep 2024 |
|
Jacobs Levy Equity Management | 547k | $558k | -20% | Sep 2024 |
|
Two Sigma Investments | 356k | $391k | 162% | Jun 2024 |
|
Tang Capital Management | 330k | $337k | 65% | Sep 2024 |
|
Bridgeway Capital Management | 325k | $358k | 0% | Jun 2024 |
|
Morgan Stanley | 244k | $269k | 310% | Jun 2024 |
|
Qube Research & Technologies | 226k | $249k | -28% | Jun 2024 |
|
Charles Schwab Investment Management | 211k | $215k | -58% | Sep 2024 |
|
Bank of New York Mellon | 181k | $184k | -24% | Sep 2024 |
|
Goldman Sachs Group | 151k | $166k | -75% | Jun 2024 |
|
Marshall Wace | 120k | $123k | -85% | Sep 2024 |
|
Barclays | 118k | $120k | 180% | Sep 2024 |
|
Nuveen Asset Management | 107k | $118k | 100% | Jun 2024 |
|
Susquehanna Fundamental Investments | 105k | $115k | 100% | Jun 2024 |
|
Rhumbline Advisers | 97k | $99k | 16% | Sep 2024 |
|
Bank of America Corporation | 91k | $93k | 68% | Sep 2024 |
|
Alpine Partners VI | 83k | $92k | 100% | Jun 2024 |
|
a16z Perennial Management | 80k | $82k | 0% | Sep 2024 |
|
Squarepoint Ops | 75k | $82k | -74% | Jun 2024 |
|
Citigroup | 61k | $62k | 238% | Sep 2024 |
|
Two Sigma Advisers | 44k | $49k | 100% | Jun 2024 |
|
Mirae Asset Global Etfs Holdings | 44k | $45k | 100% | Sep 2024 |
|
SG Americas Securities | 39k | $40k | 3% | Sep 2024 |
|
Wells Fargo & Company | 37k | $37k | 4% | Sep 2024 |
|
Jpmorgan Chase & Co | 35k | $35k | 2% | Sep 2024 |
|
Invesco | 34k | $35k | -4% | Sep 2024 |
|
Jane Street | 30k | $31k | -33% | Sep 2024 |
|
Beacon Pointe Advisors | 27k | $28k | -45% | Sep 2024 |
|
Proficio Capital Partners | 27k | $27k | 100% | Sep 2024 |
|
Sandia Investment Management | 27k | $27k | 100% | Sep 2024 |
|
T. Rowe Price Associates | 26k | $27k | 0% | Sep 2024 |
|
Graham Capital Management | 24k | $24k | -60% | Sep 2024 |
|
Susquehanna International | 23k | $23k | 13% | Sep 2024 |
|
AQR Capital Management | 20k | $21k | 100% | Sep 2024 |
|
Dimensional Fund Advisors | 17k | $18k | -73% | Sep 2024 |
|
Oxford Asset Management | 16k | $17k | 100% | Jun 2024 |
|
Ing Investment Management | 11k | $11k | 100% | Sep 2024 |
|
Modus Advisors | 11k | $11k | 0% | Sep 2024 |
|
JustInvest | 11k | $11k | -39% | Sep 2024 |
|
Naples Global Advisors | 10k | $10k | 0% | Sep 2024 |
|
Royal Bank of Canada | 9.9k | $10k | 33% | Sep 2024 |
|
Summit Investment Advisors | 7.8k | $7.9k | 0% | Sep 2024 |
|
California State Teachers Retirement System | 5.7k | $5.9k | 0% | Sep 2024 |
|
New York State Common Retirement Fund | 4.0k | $4.0k | -95% | Sep 2024 |
|
Tower Research Capital | 2.9k | $3.2k | -82% | Jun 2024 |
|
Amalgamated Bank | 2.7k | $3.0k | 0% | Sep 2024 |
|
Advisor Group Holdings | 1.3k | $1.3k | 0% | Sep 2024 |
|
Simplex Trading | 962.00 | $0 | -83% | Sep 2024 |
|
CWM | 631.00 | $1.0k | 100% | Sep 2024 |
|
Claris Advisors, Llc / Mo / | 500.00 | $510.000000 | 100% | Sep 2024 |
|
Parallel Advisors | 496.00 | $506.019200 | 100% | Sep 2024 |
|
NISA Investment Advisors | 256.00 | $260.992000 | 100% | Sep 2024 |
|
Sterling Capital Management | 252.00 | $256.989600 | 100% | Sep 2024 |
|
Aspire Private Capital | 200.00 | $204.000000 | 0% | Sep 2024 |
|
Allspring Global Investments Holdings | 157.00 | $159.998700 | 100% | Sep 2024 |
|
Capital Performance Advisors | 85.00 | $86.997500 | 100% | Sep 2024 |
|
Farther Finance Advisors | 1.00 | $1.000000 | 0% | Sep 2024 |
|
Who sold out of Adagio Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Jun 2024 | 1.1M | $1.3M |
TOMS Capital Investment Management | Jun 2024 | 699k | $768k |
Renaissance Technologies | Jun 2024 | 383k | $421k |
Man Group | Jun 2024 | 197k | $216k |
Cubist Systematic Strategies | Jun 2024 | 135k | $148k |
Balyasny Asset Management | Mar 2024 | 80k | $356k |
CornerCap Investment Counsel | Jun 2024 | 78k | $86k |
ExodusPoint Capital Management | Mar 2024 | 64k | $282k |
XTX Topco | Jun 2024 | 38k | $42k |
Marathon Trading Investment Management | Jun 2024 | 37k | $40k |
Point72 Asia | Jun 2024 | 35k | $39k |
Toroso Investments | Jun 2024 | 27k | $29k |
GSA Capital Partners | Jun 2024 | 25k | $27k |
Leucadia National Corporation | Mar 2024 | 23k | $101k |
Belvedere Trading | Jun 2024 | 20k | $22k |
OMERS Administration Corporation | Mar 2024 | 12k | $52k |
Two Sigma Securities | Mar 2024 | 10k | $45k |
Rathbones Brothers | Mar 2024 | 10k | $44k |
Macquarie Group | Mar 2024 | 4.8k | $21.049600 |
Loring Wolcott Coolidge Fa | Jun 2024 | 2.0k | $2.8k |
Federated Investors | Jun 2024 | 1.1k | $1.2k |